Valifenalate Patent Landscape Analysis

Valifenalate is an oomycete fungicide developed by Isagro, commercialised through brands such as Valis®.

The retained landscape covers 31 patent families across 23 consolidated owner groups. Fungicide combination is the thickest protection layer (26 families), with manufacturing route and formulation claims providing additional constraint.

10 of the 31 retained families carry a grant or national pending reading. 18 families are held by China-based applicants. 1 live family has a nominal term ending within five years. Position as at November 2026.

This 38-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.